{"transactions":[{"id":700526,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:33:43.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock, which vest as follows: 1/3 on July 28, 2027, with the remaining restricted stock vesting in 8 equal quarterly installments beginning October 28, 2027."}],"balance_after":76568,"source":{"system":"sec-edgar","filing":"0001437749-26-025081","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926025081/rdgdoc.xml","form_type":"4"}},{"id":1021996,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:04.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027."}],"balance_after":61568,"source":{"system":"sec-edgar","filing":"0001437749-25-030648","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925030648/rdgdoc.xml","form_type":"4"}},{"id":1021995,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:15:04.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":19606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus."}],"balance_after":49068,"source":{"system":"sec-edgar","filing":"0001437749-25-030648","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925030648/rdgdoc.xml","form_type":"4"}},{"id":1116045,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-06-10T19:06:06.000Z","date":"2025-06-09","kind":"purchase","planned":false,"acquired":true,"shares":16666,"price":1.5,"value":24999.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023."}],"balance_after":29462,"source":{"system":"sec-edgar","filing":"0001437749-25-019958","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925019958/rdgdoc.xml","form_type":"4"}},{"id":1371037,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-11-09T00:49:42.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  1/3 on November 6, 2025, with the remaining options vesting in 24 equal monthly installments beginning December 6, 2025."}],"balance_after":7000,"derivative":{"exercise_price":1.84,"expiration_date":"2034-11-06","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000912282-24-000756","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000091228224000756/form4.xml","form_type":"4"}},{"id":1807069,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-08-16T00:57:06.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  1/3 on August 11, 2024, with the remaining options vesting in 24 equal monthly installments beginning September 11, 2024."}],"balance_after":7000,"derivative":{"exercise_price":1.73,"expiration_date":"2033-08-12","underlying":"Common Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000912282-23-000305","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000091228223000305/form4.xml","form_type":"4"}},{"id":3782188,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-10-26T23:48:40.000Z","date":"2018-10-24","kind":"grant","acquired":true,"shares":337500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares which vest on October 24, 2028, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Aggregate amount indicated reflects 20-for-1 reverse split and includes additional 5,413 post-split restricted shares previously issued."}],"balance_after":359475,"source":{"system":"sec-edgar","filing":"0001213900-18-014530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018014530/ownership.xml","form_type":"4"}},{"id":4007668,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrants","published_at":"2018-03-07T21:36:19.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":226105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Warrants were issued as part of units with the shares of common stock."}],"balance_after":226105,"derivative":{"exercise_price":0.54,"exercise_date":"2018-03-06","expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":226105},"source":{"system":"sec-edgar","filing":"0001213900-18-002654","document":"f4030618disbrow_aytubio.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018002654/f4030618disbrow_aytubio.xml","form_type":"4"}},{"id":4007667,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-03-07T21:36:19.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":226105,"price":0.45,"value":101747.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 108,250 restricted shares."}],"balance_after":439490,"source":{"system":"sec-edgar","filing":"0001213900-18-002654","document":"f4030618disbrow_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018002654/f4030618disbrow_aytubio.xml","form_type":"4"}},{"id":4167255,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-11-10T00:01:26.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 8,250 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":213385,"source":{"system":"sec-edgar","filing":"0001213900-17-011708","document":"f4110717disbrow_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390017011708/f4110717disbrow_aytubio.xml","form_type":"4"}},{"id":4227368,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:58:11.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":60000,"derivative":{"exercise_price":0.82,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000786","document":"doc4_4899.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000786/doc4_4899.xml","form_type":"4"}},{"id":4227367,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:58:11.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":50000,"derivative":{"exercise_price":0.82,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000786","document":"doc4_4899.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000786/doc4_4899.xml","form_type":"4"}},{"id":4227366,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:58:11.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000786","document":"doc4_4899.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000786/doc4_4899.xml","form_type":"4"}},{"id":4227365,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-08-22T23:58:11.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000786","document":"doc4_4899.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000786/doc4_4899.xml","form_type":"4"}},{"id":4227364,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-08-22T23:58:11.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":2500000,"price":0.18,"value":450000.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.18,"exercise_date":"2017-08-15","expiration_date":"2022-08-15","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001638599-17-000786","document":"doc4_4899.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000786/doc4_4899.xml","form_type":"4"}},{"id":4227363,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-08-22T23:58:11.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":1666667,"price":0.15,"value":250000.05,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Of these shares, 165,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":2267671,"source":{"system":"sec-edgar","filing":"0001638599-17-000786","document":"doc4_4899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000786/doc4_4899.xml","form_type":"4"}},{"id":4379276,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:20:47.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":60000,"derivative":{"exercise_price":0.82,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000291","document":"doc4_4622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000291/doc4_4622.xml","form_type":"4"}},{"id":4379275,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:20:47.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":50000,"derivative":{"exercise_price":0.82,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000291","document":"doc4_4622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000291/doc4_4622.xml","form_type":"4"}},{"id":4379274,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:20:47.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.3% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2026-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001638599-17-000291","document":"doc4_4622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000291/doc4_4622.xml","form_type":"4"}},{"id":4379273,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:20:47.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These four transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33.3% vest on November 11, 2016, 33.3% vest on November 11, 2017 and 33.3% vest on November 11, 2018, subject to the Grantee's continued service as an employee on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-17-000291","document":"doc4_4622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000291/doc4_4622.xml","form_type":"4"}},{"id":4413317,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-03-01T23:43:56.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6,"exercise_date":"2016-05-06","expiration_date":"2021-05-06","underlying":"Common Stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001638599-17-000230","document":"doc4_4571.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000230/doc4_4571.xml","form_type":"4"}},{"id":4413316,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2017-03-01T23:43:56.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":166666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.86,"exercise_date":"2017-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001638599-17-000230","document":"doc4_4571.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000230/doc4_4571.xml","form_type":"4"}},{"id":4413315,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-01T23:43:56.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":187500,"price":0.75,"value":140625.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Of these shares, 165,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":601004,"source":{"system":"sec-edgar","filing":"0001638599-17-000230","document":"doc4_4571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000230/doc4_4571.xml","form_type":"4"}},{"id":4566391,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2016-11-04T20:57:47.000Z","date":"2016-11-02","kind":"purchase","acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of stock and warrants were purchased at a purchase price per unit of $1.50."}],"balance_after":166666,"derivative":{"exercise_price":1.86,"exercise_date":"2017-11-02","expiration_date":"2021-11-02","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001638599-16-001507","document":"doc4_4276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859916001507/doc4_4276.xml","form_type":"4"}},{"id":4566390,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27710,"kind":"person","name":"Disbrow Jarrett","position":1,"cik":"0001640724","reported_name":"Disbrow Jarrett","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2016-11-04T20:57:47.000Z","date":"2016-11-02","kind":"purchase","acquired":true,"shares":166666,"price":1.5,"value":249999.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of stock and warrants were purchased at a purchase price per unit of $1.50."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 165,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations."}],"balance_after":413504,"source":{"system":"sec-edgar","filing":"0001638599-16-001507","document":"doc4_4276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859916001507/doc4_4276.xml","form_type":"4"}}]}